Related Experiment Video
Updated: Jul 10, 2025
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
CRISPR-Cas System Is an Effective Tool for Identifying Drug Combinations That Provide Synergistic Therapeutic
1Department of Computational Biology, St. Jude Research Hospital, Memphis, TN 38105, USA.
Abstract:
Despite numerous efforts, the therapeutic advancement for neuroblastoma and other cancer treatments is still ongoing due to multiple challenges, such as the increasing prevalence of cancers and therapy resistance development in tumors. To overcome such obstacles, drug combinations are one of the promising applications. However, identifying and implementing effective drug combinations are critical for achieving favorable treatment outcomes. Given the enormous possibilities of combinations, a rational approach is required to predict the impact of drug combinations. Thus, CRISPR-Cas-based and other approaches, such as high-throughput pharmacological and genetic screening approaches, have been used to identify possible drug combinations. In particular, the CRISPR-Cas system (Clustered Regularly Interspaced Short Palindromic Repeats) is a powerful tool that enables us to efficiently identify possible drug combinations that can improve treatment outcomes by reducing the total search space. In this review, we discuss the rational approaches to identifying, examining, and predicting drug combinations and their impact.
Insights
Identifying effective cancer drug combinations is crucial for improving treatments. CRISPR-Cas systems offer a powerful method to efficiently discover and predict impactful drug combinations, aiding therapeutic advancements.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Cancer treatment faces challenges like rising prevalence and therapy resistance.
- Drug combinations present a promising strategy to overcome these obstacles.
- Effective identification and implementation of drug combinations are vital for successful cancer therapy.
Purpose of the Study:
- To review rational approaches for identifying, examining, and predicting the impact of drug combinations in cancer treatment.
- To highlight the role of CRISPR-Cas systems in discovering synergistic drug combinations.
Main Methods:
- Discussion of CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats) based screening.
- Exploration of high-throughput pharmacological and genetic screening approaches.
- Emphasis on rational strategies for predicting combination efficacy.
Main Results:
- CRISPR-Cas systems efficiently reduce the search space for potential drug combinations.
- These methods aid in identifying combinations that can improve therapeutic outcomes.
- The review synthesizes current approaches for evaluating drug synergy.
Conclusions:
- Rational approaches, particularly leveraging CRISPR-Cas technology, are essential for advancing cancer drug combination therapies.
- Efficiently predicting drug combination impacts can accelerate the development of more effective cancer treatments.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:59CRISPR
02:31Homologous Recombination
02:53CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...